A detailed history of Clark Capital Management Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 4,126 shares of ABT stock, worth $541,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,126
Previous 4,547 9.26%
Holding current value
$541,785
Previous $472,000 0.42%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $42,129 - $49,732
-421 Reduced 9.26%
4,126 $470,000
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $33.8 Million - $37.8 Million
-336,009 Reduced 98.66%
4,547 $472,000
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $464,802 - $513,354
-4,244 Reduced 1.23%
340,556 $38.7 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $12.3 Million - $15 Million
-136,140 Reduced 28.31%
344,800 $38 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $1.11 Million - $1.33 Million
11,570 Added 2.47%
480,940 $46.6 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $11.5 Million - $12.9 Million
114,549 Added 32.28%
469,370 $51.2 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $796,189 - $937,162
8,220 Added 2.37%
354,821 $35.9 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $5.31 Million - $6.24 Million
-55,910 Reduced 13.89%
346,601 $38.1 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $824,395 - $954,495
8,520 Added 2.16%
402,511 $38.9 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $1.26 Million - $1.52 Million
12,305 Added 3.22%
393,991 $42.8 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $4.38 Million - $5.34 Million
-38,433 Reduced 9.15%
381,686 $45.2 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $13.1 Million - $16 Million
113,003 Added 36.79%
420,119 $59.1 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $1.33 Million - $1.47 Million
11,392 Added 3.85%
307,116 $36.3 Million
Q2 2021

Aug 02, 2021

BUY
$105.79 - $124.53 $721,910 - $849,792
6,824 Added 2.36%
295,724 $34.3 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $6.08 Million - $7.16 Million
-55,829 Reduced 16.2%
288,900 $34.6 Million
Q4 2020

Jan 26, 2021

SELL
$105.0 - $114.42 $1.47 Million - $1.6 Million
-14,005 Reduced 3.9%
344,729 $37.7 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $511,351 - $620,998
-5,580 Reduced 1.53%
358,734 $39 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $11.9 Million - $15.2 Million
-155,431 Reduced 29.91%
364,314 $33.3 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $7.92 Million - $11.6 Million
126,102 Added 32.03%
519,745 $41 Million
Q4 2019

Jan 27, 2020

BUY
$78.51 - $87.4 $1.04 Million - $1.16 Million
13,278 Added 3.49%
393,643 $34.2 Million
Q3 2019

Nov 06, 2019

SELL
$81.84 - $88.74 $9.59 Million - $10.4 Million
-117,142 Reduced 23.55%
380,365 $31.8 Million
Q2 2019

Jul 12, 2019

BUY
$72.88 - $85.0 $34.8 Million - $40.5 Million
476,891 Added 2313.21%
497,507 $41.8 Million
Q1 2019

May 08, 2019

BUY
$66.22 - $80.06 $420,430 - $508,300
6,349 Added 44.5%
20,616 $1.65 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $1.17 Million - $1.32 Million
-17,798 Reduced 55.51%
14,267 $1.03 Million
Q3 2018

May 08, 2019

SELL
$60.81 - $73.36 $10,580 - $12,764
-174 Reduced 0.54%
32,065 $2.35 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $1.16 Million - $1.4 Million
19,073 Added 144.87%
32,239 $2.37 Million
Q2 2018

May 08, 2019

SELL
$57.57 - $63.54 $5,411 - $5,972
-94 Reduced 0.71%
13,166 $803,000
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $2,993 - $3,304
52 Added 0.39%
13,260 $809,000
Q1 2018

May 08, 2019

SELL
$56.27 - $63.62 $17,668 - $19,976
-314 Reduced 2.32%
13,208 $791,000
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $760,882 - $860,269
13,522 New
13,522 $810,000
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $724,304 - $775,442
-13,493 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $648,473 - $723,764
13,493
13,493 $720,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $230B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clark Capital Management Group, Inc. Portfolio

Follow Clark Capital Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.